Joseph H. Gardner is President at Aerpio Pharmaceuticals, Inc. (ARPO). They have made 3 open-market trades across 2 companies since 2017, most recently 2019-07-10.
CIK 0001700816
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
3 open-market purchases totalling $509K since 2017, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ARPO | 453,019 | $14.9M |
| PrivateUnlisted | 593,019 | — |
| Total | $14.9M |
Shares reported on the most recent Form 4, priced at the 2019-07-10 close. 1 holding could not be priced and is excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ARPO | BUY | 2019-07-10 | 2019-07-10 | $0.81 | $4K | -1.1% | -14.9% | -22.9% |
| ARPO | BUY | 2019-07-03 | 2019-07-08 | $0.90 | $5K | -3.5% | -19.1% | -25.6% |
| PrivateAerpio Pharmaceuticals, Inc. | BUY | 2017-03-15 | 2017-03-17 | $5.00 | $500K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.